Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers... see more

TSXV:EVMT - Post Discussion

View:
Post by subaru1 on Apr 02, 2024 11:16am

Halted

We are halted????Good news i hope
Comment by subaru1 on Apr 02, 2024 11:35am
For pending news.
Comment by Zibo510 on Apr 02, 2024 12:23pm
4.8 million in debt reduction and net income isn't affected, obviously Simbex wasn't very profitable.  A big step towards being debt free. As a result of the sale, Evome expects a reduction in annual revenue of ~US$6,000,000. Net income is expected to decrease immaterially. Mike
Comment by subaru1 on Apr 02, 2024 12:30pm
Good move, this new CEO is doing the job.
Comment by Zibo510 on Apr 02, 2024 12:37pm
Looks like the best is yet to come.  I believe that we have the potential to have a breakout second quarter of this year in terms of Biodex products and improvement of the balance sheet."
Comment by subaru1 on Apr 02, 2024 4:39pm
On april 16 we will have the y/e financial detail, that will give us a better idea of where we are heading, if we could have at the same time an idea of the 1qrt it would still be better. There is no conference call as far as i know.
Comment by Zibo510 on Apr 02, 2024 5:44pm
Subaru1  Mike did make this comment about upcoming Q1 I am excited to report our first quarter accomplishments soon. And lastly, I appreciate our shareholders support of me and my plan. I believe we have succeeded in saving this company, now we focus on
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities